Brief: Auris Medical Expects To Meet Requirements For CE Marking For AM-301 In Q2 Of 2021

Altamira Therapeutics

15/12/2020 13:53

Dec 15 (Reuters) - Auris Medical Holding Ltd  EARS.O :
    * AURIS MEDICAL HOLDING LTD - EXPECTS TO MEET REQUIREMENTS
FOR CE
MARKING, A PREREQUISITE FOR COMMERCIALIZING AM-301 IN EUROPE, IN
Q2 OF 2021
    * AURIS MEDICAL HOLDING LTD - ESTIMATE THAT CASH RUNWAY NOW
EXTENDS TO END OF 2021 OR INTO EARLY 2022

Source text for Eikon:  ID:nGNX3NJNwT 
Further company coverage:  EARS.O 

 ((Reuters.Briefs@thomsonreuters.com;))